Samantha Alyson Green

Title: Innovations of Samantha Alyson Green

Introduction

Samantha Alyson Green is a notable inventor based in South San Francisco, CA. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for cancer treatment. With a total of two patents to her name, her work is recognized for its potential impact on medical therapies.

Latest Patents

Samantha's latest patents include "Aza-tetracyclic oxazepine compounds and uses thereof," which presents aza-tetracyclic oxazepinyl compounds that are useful in treating cancers. Another significant patent is titled "Therapeutic compounds and methods," which provides a compound of formula (I) or a prodrug thereof, or a pharmaceutically acceptable salt thereof. These compounds are identified as agonists of the glycolytic enzyme phosphofructokinase-1 liver type, making them valuable for treating diseases associated with this enzyme's activity, such as cancer, diabetes, sepsis, and septic shock.

Career Highlights

Samantha is currently employed at Genentech, Inc., a leading biotechnology company known for its innovative approaches to drug development. Her work at Genentech has allowed her to collaborate with other talented professionals in the field.

Collaborations

Some of her notable coworkers include Elisia Villemure and Matthew Leo Landry, who contribute to the collaborative environment that fosters innovation and research at Genentech.

Conclusion

Samantha Alyson Green's contributions to the field of pharmaceuticals through her patents and work at Genentech highlight her role as an influential inventor. Her innovative compounds have the potential to significantly impact the treatment of various diseases, showcasing the importance of research and development in healthcare.